US20190175527A1 - Organic compounds - Google Patents

Organic compounds Download PDF

Info

Publication number
US20190175527A1
US20190175527A1 US16/274,357 US201916274357A US2019175527A1 US 20190175527 A1 US20190175527 A1 US 20190175527A1 US 201916274357 A US201916274357 A US 201916274357A US 2019175527 A1 US2019175527 A1 US 2019175527A1
Authority
US
United States
Prior art keywords
composition according
mannitol
alkyl
s1p receptor
receptor agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US16/274,357
Inventor
Tomoyuki Oomura
Madhusudhan Pudipeddi
Colleen Ruegger
Alan Edward Royce
Masaki Sasaki
Tokuhiro Tamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Mitsubishi Tanabe Pharma Corp
Original Assignee
Novartis AG
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US46121503P priority Critical
Priority to US10/552,005 priority patent/US20060275357A1/en
Priority to PCT/EP2004/003656 priority patent/WO2004089341A1/en
Priority to US12/191,098 priority patent/US20090203798A1/en
Priority to US12/987,726 priority patent/US20110105620A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32326722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20190175527(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US13/721,278 priority patent/US20130108675A1/en
Priority to US14/285,808 priority patent/US20140255497A1/en
Priority to US15/634,579 priority patent/US20170290787A1/en
Application filed by Novartis AG, Mitsubishi Tanabe Pharma Corp filed Critical Novartis AG
Priority to US16/274,357 priority patent/US20190175527A1/en
Publication of US20190175527A1 publication Critical patent/US20190175527A1/en
Application status is Pending legal-status Critical

Links